ProteinLogic
Cambridge · Founded 2003
About ProteinLogic
ProteinLogic develops a technology platform called ImmiPrint® that focuses on the diagnosis of tuberculosis (TB).
Company Facts
- Founded: 2003
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $5.3M
- Last round: Grant (Jan 2024)
- Website: http://www.proteinlogic.com/
- Phone: [email protected]
Industries & Categories
Health Care, Health Diagnostics, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/proteinlogic-146220 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.